Invech Holdings Remains Dormant, No Operational Shift in Q2 2025
Ticker: IVHI · Form: 10-Q · Filed: Aug 1, 2025 · CIK: 1009919
| Field | Detail |
|---|---|
| Company | Invech Holdings, Inc. (IVHI) |
| Form Type | 10-Q |
| Filed Date | Aug 1, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: Shell Company, Non-Operating, Microcap, Speculative Investment, No Revenue, SEC Filing, 10-Q
TL;DR
**IVHI is still a non-operating shell; don't expect any business activity or growth.**
AI Summary
Invech Holdings, Inc. (IVHI) filed its 10-Q for the quarter ended June 30, 2025, revealing no significant revenue or net income figures, consistent with its historical status as a non-operating entity. The company's primary financial activity revolves around its capital structure, specifically Series A Preferred Stock and Common Stock. As of June 30, 2025, the company reported a consistent balance in its Series A Preferred Stock and Common Stock, with no changes from December 31, 2024. Additional Paid-In Capital and Retained Earnings also remained static, indicating no operational changes or new capital infusions during the reporting period. The filing highlights Invech Holdings' continued existence as a shell company, with its business address listed as PO BOX 26496, Scottsdale, AZ. The company's history includes name changes from Amersin Life Sciences CORP, HUBEI PHARMACEUTICAL GROUP LTD, and PAN ASIA COMMUNICATIONS CORP, underscoring its long-standing non-operational nature. The strategic outlook remains unclear, as the filing provides no forward-looking statements or operational plans.
Why It Matters
For investors, this filing signals that Invech Holdings, Inc. (IVHI) continues to be a non-operating entity, offering no intrinsic value based on current business activities. Employees and customers are unaffected, as there are no active operations to support. The broader market impact is negligible, given the company's lack of revenue and operational footprint. In a competitive context, IVHI poses no threat or opportunity, as it does not participate in any active industry, maintaining its status as a shell company.
Risk Assessment
Risk Level: high — The risk level is high because Invech Holdings, Inc. is a non-operating entity with no reported revenue or net income for the quarter ended June 30, 2025. Its business address is a PO Box, and it has a history of multiple name changes without establishing a clear operating business, indicating a lack of fundamental business operations and potential for speculative investment.
Analyst Insight
Investors should avoid Invech Holdings, Inc. (IVHI) as it presents no operational business or financial performance. This filing confirms its status as a shell company, making it a highly speculative and risky investment with no clear path to generating returns.
Financial Highlights
- debt To Equity
- 0.0
- revenue
- $0
- operating Margin
- N/A
- total Assets
- $0
- total Debt
- $0
- net Income
- $0
- eps
- $0.00
- gross Margin
- N/A
- cash Position
- $0
- revenue Growth
- 0.0%
Key Numbers
- $0 — Revenue (No revenue reported for the quarter ended June 30, 2025, indicating a non-operating entity.)
- $0 — Net Income (No net income reported for the quarter ended June 30, 2025, consistent with no operations.)
- 2025-06-30 — Conformed Period of Report (The end date of the financial period covered by this 10-Q filing.)
- 2025-08-01 — Filed As Of Date (The date the 10-Q was officially filed with the SEC.)
Key Players & Entities
- Invech Holdings, Inc. (company) — filer of the 10-Q
- Amersin Life Sciences CORP (company) — former name of Invech Holdings, Inc.
- HUBEI PHARMACEUTICAL GROUP LTD (company) — former name of Invech Holdings, Inc.
- PAN ASIA COMMUNICATIONS CORP (company) — former name of Invech Holdings, Inc.
- SEC (regulator) — recipient of the 10-Q filing
- 07 Trade & Services (company) — organization name associated with the filer
- Scottsdale (location) — city of business address
- AZ (location) — state of business address
- NV (location) — state of incorporation
FAQ
What is Invech Holdings, Inc.'s current business status?
Invech Holdings, Inc. (IVHI) is currently a non-operating entity, as evidenced by its 10-Q filing for the quarter ended June 30, 2025, which reports no revenue or net income.
Did Invech Holdings, Inc. generate any revenue in Q2 2025?
No, Invech Holdings, Inc. (IVHI) did not report any revenue for the quarter ended June 30, 2025, indicating a lack of active business operations.
What are the key financial figures for Invech Holdings, Inc. as of June 30, 2025?
As of June 30, 2025, Invech Holdings, Inc. reported consistent balances in Series A Preferred Stock, Common Stock, Additional Paid-In Capital, and Retained Earnings, with no changes from December 31, 2024, and no reported revenue or net income.
What is the risk associated with investing in Invech Holdings, Inc. (IVHI)?
Investing in Invech Holdings, Inc. (IVHI) carries a high risk due to its status as a non-operating shell company with no revenue, no active business, and a history of name changes without establishing operations.
Has Invech Holdings, Inc. changed its name recently?
While Invech Holdings, Inc. has a history of name changes (Amersin Life Sciences CORP, HUBEI PHARMACEUTICAL GROUP LTD, PAN ASIA COMMUNICATIONS CORP), the current filing does not indicate a recent name change, only its historical evolution.
Where is Invech Holdings, Inc.'s business located?
Invech Holdings, Inc.'s business address is listed as PO BOX 26496, Scottsdale, AZ 85255, which is a post office box, further indicating a lack of physical operational presence.
What does the 10-Q filing for Invech Holdings, Inc. tell investors?
The 10-Q filing for Invech Holdings, Inc. (IVHI) for Q2 2025 informs investors that the company remains a non-operating entity with no business activities, revenue, or net income, suggesting it is a highly speculative investment.
Are there any strategic plans outlined in Invech Holdings, Inc.'s latest 10-Q?
No, the 10-Q filing for Invech Holdings, Inc. (IVHI) for the quarter ended June 30, 2025, does not outline any strategic plans, operational outlooks, or future business initiatives.
What is the significance of Invech Holdings, Inc. being classified under 'SERVICES-MANAGEMENT CONSULTING SERVICES'?
Despite its SIC classification as 'SERVICES-MANAGEMENT CONSULTING SERVICES [8742]', the 10-Q filing for Invech Holdings, Inc. (IVHI) shows no actual operational activity or revenue in this sector, indicating a discrepancy between its classification and current business reality.
How has Invech Holdings, Inc.'s capital structure changed in Q2 2025?
Invech Holdings, Inc.'s capital structure, including Series A Preferred Stock, Common Stock, Additional Paid-In Capital, and Retained Earnings, showed no changes during the quarter ended June 30, 2025, remaining consistent with balances from December 31, 2024.
Industry Context
Invech Holdings, Inc. is classified under 'SERVICES-MANAGEMENT CONSULTING SERVICES' (SIC 8742). However, its current financial filings indicate it is a non-operating entity. This sector typically involves advisory services for businesses, but Invech's lack of revenue suggests it is not actively participating in this market.
Regulatory Implications
As a publicly traded entity, Invech Holdings must comply with SEC reporting requirements, including timely filing of 10-Q forms. The consistent lack of operational activity and financial reporting may attract scrutiny regarding its status and purpose as a public company.
What Investors Should Do
- Monitor for future filings
- Assess capital structure stability
- Evaluate potential for reverse merger or acquisition
Key Dates
- 2025-06-30: Quarter End — Marks the end of the reporting period for the 10-Q filing.
- 2025-08-01: 10-Q Filing Date — The date the company officially submitted its quarterly report to the SEC.
- 2005-03-01: Name Change from Amersin Life Sciences CORP — Indicates a historical restructuring or shift in focus, common for shell companies.
- 2003-04-09: Name Change from HUBEI PHARMACEUTICAL GROUP LTD — Further historical evidence of corporate identity changes.
- 1999-02-24: Name Change from PAN ASIA COMMUNICATIONS CORP — Long-standing history of corporate name changes, reinforcing non-operational status.
Glossary
- 10-Q
- A quarterly report required by the U.S. Securities and Exchange Commission (SEC) that provides a comprehensive update on a company's financial performance. (This filing provides the primary data for this analysis, detailing Invech Holdings' financial status for the quarter.)
- Series A Preferred Stock
- A class of preferred stock that has priority over common stock in dividend payments and asset distribution in case of liquidation. (A significant component of Invech Holdings' capital structure, with a static balance indicating no new capital or changes.)
- Additional Paid-In Capital
- The amount of money a company receives from selling stock above its par value. (A static balance suggests no new equity issuances or capital raises during the period.)
- Retained Earnings
- The cumulative amount of net income that a company has retained over time, rather than distributing to shareholders as dividends. (A static balance reinforces the lack of operational activity and profitability.)
- Non-operating entity
- A company that does not conduct active business operations, often existing as a shell company for holding assets or for potential future transactions. (Describes the current state of Invech Holdings, Inc., as evidenced by zero revenue and net income.)
Year-Over-Year Comparison
The 10-Q filing for the quarter ended June 30, 2025, shows no change in key financial metrics compared to the prior period (December 31, 2024, or the previous quarter). Revenue and net income remain at $0, and balances for Series A Preferred Stock, Common Stock, Additional Paid-In Capital, and Retained Earnings are static. No new risks or operational developments were disclosed, consistent with its historical profile as a non-operating entity.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on August 1, 2025 regarding Invech Holdings, Inc. (IVHI).